Clinical Trial Update: Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in a Cyclosporine Microemulsion Based Regimen in de Novo Living Donor Kidney Transplant Recipients [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the efficacy and safety of enteric-coated mycophenolate sodium (EC-MPS) in combination with a cyclosporine microemulsion regimen in de …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Cyclosporine (cyclosporine microemulsion) (cyclosporine)
• Enteric-coated Mycophenolate Sodium (EC-MPS) (mycophenolate sodium)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Kidney Transplant | Phase 4 | Status: COMPLETED